Une double valvulopathie médicamenteuse induite par la dexfenfluramine associée à une cardiomyopathie hypertrophique : une association fatale.

The article provides information on the case study of double drug heart valve disease induced by dexfenfluramine associated with hypertrophic cardiomyopathy. Topics include use of fenfluramine, risk of pulmonary arterial hypertension and case of restrictive cardiopathy by endocardial fibrosis reported in a old woman treated with the fenfluramine phentermine combination.